Risk factors for unsuccessful tuberculosis treatment outcomes in children
Autoři:
Meherunissa Hamid aff001; Meredith B. Brooks aff002; Falak Madhani aff001; Hassan Ali aff001; Mohammad Junaid Naseer aff001; ; Mercedes Becerra aff002; Farhana Amanullah aff001
Působiště autorů:
Global Health Directorate, The Indus Health Network, Karachi, Sindh, Pakistan
aff001; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America
aff002; Department of Pediatrics, The Indus Hospital, Karachi, Sindh, Pakistan
aff003
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pone.0222776
Souhrn
Objective
Pakistan has a high pediatric burden of tuberculosis, but few studies describe the treatment experience of children with tuberculosis in Pakistan. We sought to identify risk factors for unsuccessful treatment outcomes in children with drug-susceptible tuberculosis identified in eight hospitals in Karachi, Pakistan.
Design
We conducted a retrospective cohort study among children (<15 years old) treated with first-line anti-tuberculosis drugs for presumed or confirmed drug-susceptible tuberculosis between 2016 and 2017. We assessed risk factors for experiencing an unsuccessful treatment outcome through multivariable logistic regression analysis.
Results
In total, 1,665 children initiated tuberculosis treatment, including 916 (55.0%) identified through intensified case finding. Unsuccessful treatment outcomes were experienced by 197 (11.8%) children, comprising 27 (1.6%) deaths, 16 (1.0%) treatment failures, and 154 (9.3%) lost to follow-up. An additional 47 (2.8%) children had outcomes not evaluable. In multivariable analysis, children 0–4 years old (OR: 1.80, 95% CI: 1.07–3.04), males (OR: 1.48, 95% CI: 1.04, 2.11), and those with bacteriologic confirmation of disease (OR: 3.39, 95% CI: 1.98, 5.80) had increased odds of experiencing an unsuccessful treatment outcome.
Conclusion
Our findings suggest a need to deploy strategies to identify children earlier in the disease process and point to the need for interventions tailored for young children once treatment is initiated.
Klíčová slova:
Bacterial pathogens – Drug therapy – Child health – Children – Medical risk factors – Sputum – Tuberculosis – Tuberculosis diagnosis and management
Zdroje
1. Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014; 2:e453–59. doi: 10.1016/S2214-109X(14)70245-1 25103518
2. Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Perez-Velez CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014; 383:1572–79. doi: 10.1016/S0140-6736(14)60195-1 24671080
3. World Health Organization. Global Tuberculosis Report 2018. WHO; 2018. Geneva, Switzerland.
4. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Pediatric tuberculosis. Lancet Infect Dis. 2008; 8:498–510. doi: 10.1016/S1473-3099(08)70182-8 18652996
5. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J TubercLung Dis. 2002; 6:1038–45.
6. Seddon JA, Shingadia D. Epidemiology and disease burden of tuberculosis in children: a global perspective. Infect Drug Resist. 2014; 7:153–65. doi: 10.2147/IDR.S45090 24971023
7. Ogbudebe CL, Adepoju V, Ekerete-Udofia C, Abu E, Egesemba G, Chukwueme N, et al. Childhood Tuberculosis in Nigeria: Disease Presentation and Treatment Outcomes. Health Serv Insights. 2018; 11:1178632918757490. doi: 10.1177/1178632918757490 29511357
8. Tilahun G, Gebre-Selassie S. Treatment outcomes of childhood tuberculosis in Addis Ababa: A five-year retrospective analysis. BMC Public Health. 2016; 16(1): doi: 10.1186/s12889-016-3193-8 27443308
9. Aw B, Ade S, Hinderaker SG, Dlamini N, Takarinda KC, Chiaa K, et al. Childhood tuberculosis in Mauritania, 2010–2015: diagnosis and outcomes in Nouakchott and the rest of the country. Public Health Action. 2017; 7(3):199–205. doi: 10.5588/pha.16.0123 29201655
10. Alavi SM, Salmanzadeh S, Bakhtiyariniya P, Albagi A, Hemmatnia F, Alavi L. Prevalence and treatment outcome of pulmonary and extrapulmonary pediatric tuberculosis in southwestern Iran. Caspian J Intern Med. 2015; 6(4):213–219. 26644895
11. Laghari M, Sulaiman SA, Khan AH, Memon N. Epidemiology of tuberculosis and treatment outcomes among children in Pakistan: a 5 year retrospective study. Peer J. 2018; 6:e5253. doi: 10.7717/peerj.5253 30065869
12. Ho J, Fox GJ, Marais BJ. Passive case finding for tuberculosis is not enough. Int J Mycobacteriol. 2016; 5:374–8. doi: 10.1016/j.ijmyco.2016.09.023 27931676
13. Doctor’s desk guide, Management of Childhood Tuberculosis, 2017, National TB Control Programme, Ministry of Health, Government of Pakistan.
14. Definitions and reporting framework for tuberculosis—2013 revision. Geneva, World Health Organization, 2013 (WHO/HTM/TB/2013.2).
15. Aketi L, Kashongwe Z, Kinsiona C, Fueza S, Kokolomami J, Bolie G, et al. Childhood tuberculosis in a sub-saharan tertiary facility: epidemiology and factors associated with treatment outcome. PLOS ONE. 2016; 11:e0153914. doi: 10.1371/journal.pone.0153914 27101146
16. Satyanarayana S, Shivashankar R, Vashist R, Chauhan L, Chadha S, Dewan P, et al. Characteristics and programme-defined treatment outcomes among childhood tuberculosis patients under the national TB programme in Delhi. PLOS ONE. 2010; 5:e13338. doi: 10.1371/journal.pone.0013338 20967279
17. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, Beyers N. The Bacteriologic Yield in Children with Intrathoracic Tuberculosis. Clin Infect Dis. 2016; 42(8):e69–e71.
18. Harries A, Graham S, Weismuller M, Claessens N, Meijnen S, Hargreaves N, et al. Childhood tuberculosis in Malawi: caseload, diagnostic practices and treatment outcomes. Malawi Med J. 2006; 17(4).
Článek vyšel v časopise
PLOS One
2019 Číslo 9
- S diagnostikou Parkinsonovy nemoci může nově pomoci AI nástroj pro hodnocení mrkacího reflexu
- Je libo čepici místo mozkového implantátu?
- Pomůže v budoucnu s triáží na pohotovostech umělá inteligence?
- AI může chirurgům poskytnout cenná data i zpětnou vazbu v reálném čase
- Nová metoda odlišení nádorové tkáně může zpřesnit resekci glioblastomů
Nejčtenější v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania
Zvyšte si kvalifikaci online z pohodlí domova
Všechny kurzy